US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist
  • 1.5300
  • -0.0900-5.56%
Close Mar 26 16:00 ET
14.12MMarket Cap-0.24P/E (TTM)

About SAB Biotherapeutics Company

SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company. It is engaged in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. SAB Biotherapeutics was founded by Eddie J. Sullivan and Christine E. Hamilton in July 2014 and is headquartered in Miami Beach, FL.

Company Profile

SymbolSABS
Company NameSAB Biotherapeutics
Listing DateFeb 9, 2021
Founded2014
CEOMr. Samuel J. Reich
MarketNASDAQ
Employees57
Fiscal Year Ends12-31
Address777 West 41st Street,Suite 401
CityMiami Beach
ProvinceFlorida
CountryUnited States of America
Zip Code33140
Phone1-605-679-6980

Company Executives

  • Name
  • Position
  • Salary
  • Samuel J. Reich
  • Chief Executive Officer and Director
  • 565.80K
  • Christoph Lawrence Bausch
  • Chief Operating Officer
  • 549.32K
  • Lucy To
  • Chief Financial Officer
  • --
  • Dr. Alexandra Kropotova, M.D.
  • Chief Medical Officer and Executive Vice President
  • 921.58K
  • Mark William Conley, C.P.A.
  • Vice President, Finance
  • --
  • Dr. Eddie J. Sullivan, PhD
  • Director and President
  • 202.60K
  • David Link, M.B.A.
  • Vice Chairman of the Board
  • 25.00K
  • Dr. Jay S. Skyler,M.D.,M.A.C.P.
  • Director
  • --
  • Andrew D. Moin
  • Independent Director
  • --
  • Christine Hamilton, M.B.A.
  • Independent Director
  • 25.00K
  • Admiral Scott Giberson, (Ret.)
  • Independent Director
  • 25.00K
  • Helen Katherine Ellias
  • Independent Director
  • --
  • Jeffrey G. Spragens
  • Independent Director
  • 25.00K
  • Erick J. Lucera, C.F.A.
  • Independent Director
  • 26.93K
  • Dr. William J. Polvino, M.D.
  • Independent Director
  • 25.00K

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More